ATE110375T1 - 1-phenylalkyl-3-phenylharnstoff-derivate. - Google Patents

1-phenylalkyl-3-phenylharnstoff-derivate.

Info

Publication number
ATE110375T1
ATE110375T1 AT91100515T AT91100515T ATE110375T1 AT E110375 T1 ATE110375 T1 AT E110375T1 AT 91100515 T AT91100515 T AT 91100515T AT 91100515 T AT91100515 T AT 91100515T AT E110375 T1 ATE110375 T1 AT E110375T1
Authority
AT
Austria
Prior art keywords
phenylalkyl
integer
alkyl
alkoxyl
halo
Prior art date
Application number
AT91100515T
Other languages
English (en)
Inventor
Tetsuo Sekiya
Shinya Inoue
Chiaki Hyodo
Hiromi Okushima
Kohei Umezu
Kazuo Suzuki
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Application granted granted Critical
Publication of ATE110375T1 publication Critical patent/ATE110375T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
AT91100515T 1990-01-22 1991-01-17 1-phenylalkyl-3-phenylharnstoff-derivate. ATE110375T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1223590 1990-01-22
JP2876890 1990-02-08

Publications (1)

Publication Number Publication Date
ATE110375T1 true ATE110375T1 (de) 1994-09-15

Family

ID=26347808

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91100515T ATE110375T1 (de) 1990-01-22 1991-01-17 1-phenylalkyl-3-phenylharnstoff-derivate.

Country Status (10)

Country Link
US (1) US5202351A (de)
EP (1) EP0439059B1 (de)
JP (1) JPH05310678A (de)
KR (1) KR910014366A (de)
AT (1) ATE110375T1 (de)
AU (1) AU636946B2 (de)
CA (1) CA2034673A1 (de)
DE (1) DE69103535T2 (de)
DK (1) DK0439059T3 (de)
ES (1) ES2057608T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL100915A (en) * 1991-02-19 1996-03-31 Erba Carlo Spa Disubstituted ureas and thioureas their preparation and pharmaceutical compositions containing them
JPH07503737A (ja) * 1992-05-28 1995-04-20 フアイザー・インコーポレイテツド アシル補酵素a:コレステロールアシルトランスフェラーゼ(acat)の阻害剤としての新規なn−アリールおよびn−ヘテロアリール尿素誘導体
CA2107196A1 (en) * 1992-09-29 1994-03-30 Mitsubishi Chemical Corporation Carboxamide derivatives
US5534529A (en) * 1993-06-30 1996-07-09 Sankyo Company, Limited Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
RU2128165C1 (ru) * 1995-09-18 1999-03-27 Санкио Компани Лимитед Производные амидов и композиция, обладающая асат-ингибирующей активностью
CA2190041A1 (en) * 1995-11-13 1997-05-14 Shinya Inoue Urea derivatives
OA12173A (en) 2000-02-02 2006-05-08 Warner Lambert Co Dual inhibitors of cholesterol ester and wax estersynthesis for sebaceous gland disorders.
PL1682528T3 (pl) 2003-11-07 2008-01-31 Hoffmann La Roche Pochodne benzo[b][1,4]dioksepiny

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2485600A (en) * 1946-04-01 1949-10-25 Harold W Moburg Derivatives of safrol and isosafrol
FR6183M (de) * 1967-03-10 1968-07-15
US4102673A (en) * 1971-06-21 1978-07-25 Hercules Incorporated 1-Phenyl-hexyl ureas as herbicides
JPS5312844A (en) * 1976-07-20 1978-02-04 Nippon Tokushu Noyaku Seizo Kk Nn44halogenobenzyllnnmethyl*or nonsubstitutedd*cycloalkylln**phenylurea or thiourea compounds* their preparation and fungicides containing the same as active constituents
DE2928485A1 (de) * 1979-07-14 1981-01-29 Bayer Ag Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
US4473579A (en) * 1982-01-26 1984-09-25 American Cyanamid Company Antiatherosclerotic tetrasubstituted ureas and thioureas
ES2060682T3 (es) * 1988-03-30 1994-12-01 Warner Lambert Co N-((fenil(2,6-disubstituido))-n'-aril)ureas como agentes antihipercolesterolemicos y antiateroscleroticos.
US4868210A (en) * 1988-03-30 1989-09-19 Warner-Lambert Company Antihyperlipidemic and antiatherosclerotic compounds and compositions
IL89997A0 (en) * 1988-04-25 1989-12-15 Lilly Co Eli Propanamine derivatives
JPH02124884A (ja) * 1988-07-08 1990-05-14 Zhongguo Yixuekexueyuan Yaowo Yanjiusuo N―置換アミド誘導体
CA2010184A1 (en) * 1989-02-17 1990-08-17 Bharat K. Trivedi Antihyperlipidemic and antiatherosclerotic trisubstituted urea compounds
AU629376B2 (en) * 1989-08-04 1992-10-01 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives

Also Published As

Publication number Publication date
EP0439059B1 (de) 1994-08-24
KR910014366A (ko) 1991-08-31
EP0439059A2 (de) 1991-07-31
ES2057608T3 (es) 1994-10-16
EP0439059A3 (en) 1991-11-13
US5202351A (en) 1993-04-13
DK0439059T3 (da) 1994-12-19
DE69103535T2 (de) 1995-01-26
JPH05310678A (ja) 1993-11-22
AU6948291A (en) 1991-07-25
AU636946B2 (en) 1993-05-13
CA2034673A1 (en) 1991-07-23
DE69103535D1 (de) 1994-09-29

Similar Documents

Publication Publication Date Title
DK0405233T3 (da) Diphenylurinstofderivater
NZ272015A (en) Treatment of insufficiency of central choline functions using a cyclic amide (substituted 1,3-benzoxazin-2-one derivative)
GEP19970833B (en) Method for production of macrocyclic compounds
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
GR3036455T3 (en) Atherosclerosis treatment
ES2093041T3 (es) Derivados de 2-oxo-(1,8-naftiridina).
DK0479546T3 (da) Piperazinderivater
DE69103535D1 (de) 1-Phenylalkyl-3-Phenylharnstoff-Derivate.
DK0559533T3 (da) Fremgangsmåde til fremstilling af beta-lactamderivat og syntetisk mellemprodukt deraf
KR0184608B1 (en) Novel benzopyran derivative
AU3381389A (en) Derivative of caffeic acid and pharmaceutical composition containing the same
DE69014775D1 (de) 1-Phenylalkyl-phenylharnstoff-Derivate.
BR8606955A (pt) Processo para preparar uma composicao,concentrado aditivo,composicao lubrificante,composicao combustivel e metodo para reduzir o consumo de combustivel
DK0411394T3 (da) Imidazoquinolon-derivater
FI914525A0 (fi) Foerening, anvaendning och framstaellning.
DE3879058D1 (de) 4-piperidincarboxamid-derivate.
NO941757D0 (no) 1-fenylpyrrolidon-derivater med optisk aktivitet, mellomprodukter for fremstilling derav og fremgangsmåter for deres fremstilling
ATE33983T1 (de) N-substituierte tetrahydrothiazine, verfahren zu deren herstellung und deren verwendung als pestizide.